Background Short-term treatment for people with type 2 diabetes using a low dose of the
selective endothelin A receptor antagonist atrasentan reduces albuminuria without causing …

Antiproteinuric effect of oral paricalcitol in chronic kidney disease. Background Proteinuria
is a marker of cardiovascular and renal disease in patients with chronic kidney disease (CKD)…

Background/Aims: Vitamin D insufficiency and secondary hyperparathyroidism (SHPT) are
associated with increased morbidity and mortality in chronic kidney disease (CKD) and are …

Background. Abnormalities of serum calcium, phosphorous and intact parathyroid hormone (PTH)
are associated with morbidity and mortality in haemodialysis patients. Pharmacologic …

Background/Aims: Vitamin D insufficiency drives secondary hyperparathyroidism (SHPT)
and is associated with increased cardiovascular mortality in patients with chronic kidney …

Background/Aims: Secondary hyperparathyroidism is a common complication of chronic
kidney disease, resulting from inactivation of vitamin D receptor signaling and phosphate …

Chronic metabolic acidosis increases proximal tubular citrate uptake and metabolism. The
present study addressed the effect of chronic metabolic acidosis on a cytosolic enzyme of …

Objectives This double-blind randomized controlled trial investigated raising serum 25-hydroxyvitamin
D (25D) with extended-release calcifediol (ERC) on time to symptom resolution in …

BACKGROUND: Secondary hyperparathyroidism is a common complication in children
receiving hemodialysis. Active vitamin D is an effective therapy, but its use is often limited by …

Nephrotoxicity manifested by renal insufficiency is a well-known consequence of
aminoglycoside administration in hospitalized patients. We report two cases of aminoglycoside-…